Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Prognostic Value of a Novel Nuclear Grading of Cutaneous Melanoma: The UNC Chapel Hill Method.
Journal: The American journal of surgical pathology
Published: January 13, 2026
Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer.
Journal: The oncologist
Published: July 15, 2025
Anatomic Location Predicts Response Rates: Real World Outcomes With Over 1100 Cycles of Talimogene Laherparepvec Description: A Retrospective Review of a Prospectively Maintained Database.
Journal: Annals of surgery
Published: April 29, 2025
Exploring the Role of Patient Preferences in Hepatocellular Carcinoma Treatment Decisions: A Qualitative Study.
Journal: MDM policy & practice
Published: December 04, 2024
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.
Journal: The oncologist
Published: February 20, 2024
Clinical and Histological Response to Talimogene Laherparepvec Therapy in Advanced Melanoma: Impact on Overall Survival.
Journal: Journal of the American College of Surgeons
Published: January 15, 2024
Seeking Racial Equity in Hematology and Oncology: a Fellow-Led Educational Series to Promote Reflection and Action.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: December 14, 2022
Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer.
Journal: The oncologist
Published: August 09, 2022
Brief Report: Improving Fellow Performance of the Pharmacology Section of the American Society of Clinical Oncology In-Training Exam.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: September 09, 2021
Incidence and Prediction of Immune Checkpoint Inhibitor-related Nephrotoxicity.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: June 20, 2020
Last Updated: 09/26/2026